Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001802768-25-000027
Filing Date
2025-05-08
Accepted
2025-05-08 09:14:25
Documents
76
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rprx-20250331.htm   iXBRL 10-Q 1739122
2 EX-10.1 rprx-20250331ex101.htm EX-10.1 1335522
3 EX-31.1 rprx-20250331ex311.htm EX-31.1 9563
4 EX-31.2 rprx-20250331ex312.htm EX-31.2 9598
5 EX-32 rprx-20250331ex32.htm EX-32 4863
  Complete submission text file 0001802768-25-000027.txt   10423930

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20250331.xsd EX-101.SCH 72702
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20250331_cal.xml EX-101.CAL 85341
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20250331_def.xml EX-101.DEF 402214
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20250331_lab.xml EX-101.LAB 744974
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20250331_pre.xml EX-101.PRE 542908
78 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20250331_htm.xml XML 1232273
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39329 | Film No.: 25924165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)